{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:07:31Z","timestamp":1795176451489,"version":"4.10.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-pulmonary vein (PV) ablation targets such as posterior wall isolation (PWI) have been tested in patients with persistent atrial fibrillation (AF). Pulsed-field ablation (PFA) offers a novel ablation technology possibly able to overcome the obstacles of incomplete PWI and concerns of damage to adjacent structures compared to thermal energy sources. Our aim was to assess procedural characteristics, safety, and mid-term outcomes of patients undergoing PWI using PFA in a clinical setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients undergoing PFA-PVI with PWI were included. First-pass isolation was controlled using a multipolar mapping catheter.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred consecutive patients were included (median age 69 [IQR 63\u201375] years, 33 females (33%), left atrial size 43 [IQR 39\u201347] mm, paroxysmal AF 24%). Median procedure time was 66 (IQR 59\u201377) min, and fluoroscopy time was 11 (8\u201314) min. PWI using PFA was achieved in 100% of patients with a median of 19 applications (IQR 14\u201326). There were no major complications. Overall, in 15 patients (15%), recurrent AF\/AT was noted during a median follow-up of 144 (94\u2013279) days.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PWI using PFA appears safe and results in high acute isolation rates and high arrhythmia survival during mid-term follow-up. Further randomized trials are essential and warranted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s10840-023-01728-0","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T17:01:58Z","timestamp":1704474118000},"page":"1359-1364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Left atrial posterior wall isolation using pulsed-field ablation: procedural characteristics, safety, and mid-term outcomes"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9751-0557","authenticated-orcid":false,"given":"Patrick","family":"Badertscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Mannhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Weidlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Krisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian","family":"Voellmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sticherling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"2","key":"1728_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jama.2022.23722","volume":"329","author":"PM Kistler","year":"2023","unstructured":"Kistler PM, Chieng D, Sugumar H, et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA Randomized Clinical Trial. JAMA. 2023;329(2):127\u201335. https:\/\/doi.org\/10.1001\/jama.2022.23722.","journal-title":"JAMA"},{"issue":"12","key":"1728_CR2","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/europace\/euab161","volume":"23","author":"DG Della Rocca","year":"2021","unstructured":"Della Rocca DG, Di Biase L, Mohanty S, et al. Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry. Europace. 2021;23(12):1939\u201349. https:\/\/doi.org\/10.1093\/europace\/euab161.","journal-title":"Europace"},{"issue":"8","key":"1728_CR3","doi-asserted-by":"publisher","first-page":"e007005","DOI":"10.1161\/CIRCEP.118.007005","volume":"12","author":"A Thiyagarajah","year":"2019","unstructured":"Thiyagarajah A, Kadhim K, Lau DH, et al. Feasibility, safety, and efficacy of posterior wall isolation during atrial fibrillation ablation: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2019;12(8):e007005. https:\/\/doi.org\/10.1161\/CIRCEP.118.007005.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"1728_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/europace\/euac211","volume":"25","author":"S Tohoku","year":"2023","unstructured":"Tohoku S, Chun KRJ, Bordignon S, et al. Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation. Europace. 2023;25(2):433\u201340. https:\/\/doi.org\/10.1093\/europace\/euac211.","journal-title":"Europace"},{"issue":"7","key":"1728_CR5","doi-asserted-by":"publisher","first-page":"euad185","DOI":"10.1093\/europace\/euad185","volume":"25","author":"B Schmidt","year":"2023","unstructured":"Schmidt B, Bordignon S, Neven K, et al. EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace. 2023;25(7):euad185. https:\/\/doi.org\/10.1093\/europace\/euad185.","journal-title":"Europace"},{"issue":"9","key":"1728_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.hrthm.2023.05.007","volume":"20","author":"P Badertscher","year":"2023","unstructured":"Badertscher P, Weidlich S, Serban T, et al. Pulsed-field ablation versus single-catheter high-power short-duration radiofrequency ablation for atrial fibrillation: procedural characteristics, myocardial injury, and mid-term outcomes. Heart Rhythm. 2023;20(9):1277\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2023.05.007.","journal-title":"Heart Rhythm"},{"issue":"4","key":"1728_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/jce.14933","volume":"32","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Kiuchi K, Fukuzawa K, et al. Late-gadolinium enhancement properties associated with atrial fibrillation rotors in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32(4):1005\u201313. https:\/\/doi.org\/10.1111\/jce.14933.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"1728_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jacep.2020.04.015","volume":"6","author":"TE Walters","year":"2020","unstructured":"Walters TE, Lee G, Lee A, Sievers R, Kalman JM, Gerstenfeld EP. Site-specific epicardium-to-endocardium dissociation of electrical activation in a swine model of atrial fibrillation. JACC Clin Electrophysiol. 2020;6(7):830\u201345. https:\/\/doi.org\/10.1016\/j.jacep.2020.04.015.","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"1728_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jacep.2019.08.021","volume":"5","author":"JM Lee","year":"2019","unstructured":"Lee JM, Shim J, Park J, et al. The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation. JACC Clin Electrophysiol. 2019;5(11):1253\u201361. https:\/\/doi.org\/10.1016\/j.jacep.2019.08.021.","journal-title":"JACC Clin Electrophysiol"},{"key":"1728_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijcard.2014.12.035","volume":"181","author":"JS Kim","year":"2015","unstructured":"Kim JS, Shin SY, Na JO, et al. Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation? Int J Cardiol. 2015;181:277\u201383. https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.035.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1728_CR11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/CIRCEP.111.970293","volume":"5","author":"TW Lim","year":"2012","unstructured":"Lim TW, Koay CH, See VA, et al. Single-ring posterior left atrial (box) isolation results in a different mode of recurrence compared with wide antral pulmonary vein isolation on long-term follow-up: longer atrial fibrillation-free survival time but similar survival time free of any atrial arrhythmia. Circ Arrhythm Electrophysiol. 2012;5(5):968\u201377. https:\/\/doi.org\/10.1161\/CIRCEP.111.970293.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"1728_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10840-011-9587-8","volume":"32","author":"K Chilukuri","year":"2011","unstructured":"Chilukuri K, Scherr D, Dalal D, et al. Conventional pulmonary vein isolation compared with the \u201cbox isolation\u201d method: a randomized clinical trial. J Interv Card Electrophysiol. 2011;32(2):137\u201346. https:\/\/doi.org\/10.1007\/s10840-011-9587-8.","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"1728_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCEP.108.797944","volume":"2","author":"D Tamborero","year":"2009","unstructured":"Tamborero D, Mont L, Berruezo A, et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol. 2009;2(1):35\u201340. https:\/\/doi.org\/10.1161\/CIRCEP.108.797944.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"1728_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/jce.14379","volume":"31","author":"T Shigeta","year":"2020","unstructured":"Shigeta T, Okishige K, Nishimura T, et al. Clinical investigation of the durability of the lesions created by left atrial linear ablation with a cryoballoon. J Cardiovasc Electrophysiol. 2020;31(4):875\u201384. https:\/\/doi.org\/10.1111\/jce.14379.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"1728_CR15","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.hrthm.2020.05.005","volume":"17","author":"TM Markman","year":"2020","unstructured":"Markman TM, Hyman MC, Kumareswaran R, et al. Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation. Heart Rhythm. 2020;17(10):1740\u20134. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.005.","journal-title":"Heart Rhythm"},{"issue":"9","key":"1728_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.hrthm.2010.02.027","volume":"7","author":"M Martinek","year":"2010","unstructured":"Martinek M, Meyer C, Hassanein S, et al. Identification of a high-risk population for esophageal injury during radiofrequency catheter ablation of atrial fibrillation: procedural and anatomical considerations. Heart Rhythm. 2010;7(9):1224\u201330. https:\/\/doi.org\/10.1016\/j.hrthm.2010.02.027.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1728_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/europace\/euac113","volume":"25","author":"V Miraglia","year":"2023","unstructured":"Miraglia V, Lipartiti F, Del Monte A, Chierchia GB, de Asmundis C, Str\u00f6ker E. Unexpected fused posterior wall lesions after pulsed-field pulmonary vein isolation. Europace. 2023;25(1):64. https:\/\/doi.org\/10.1093\/europace\/euac113.","journal-title":"Europace"},{"issue":"9","key":"1728_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jacc.2020.07.007","volume":"76","author":"VY Reddy","year":"2020","unstructured":"Reddy VY, Anic A, Koruth J, et al. Pulsed field ablation in patients with persistent atrial fibrillation. J Am Coll Cardiol. 2020;76(9):1068\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2020.07.007.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1728_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ijcard.2008.10.004","volume":"139","author":"N Dagres","year":"2010","unstructured":"Dagres N, Kottkamp H, Piorkowski C, et al. Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: implications for patient follow-up. Int J Cardiol. 2010;139(3):305\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2008.10.004.","journal-title":"Int J Cardiol"},{"issue":"5","key":"1728_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cjco.2022.02.001","volume":"4","author":"RR Unni","year":"2022","unstructured":"Unni RR, Prager RT, Odabashian R, et al. Rhythm-monitoring strategy and arrhythmia recurrence in atrial fibrillation ablation trials: a systematic review. CJC Open. 2022;4(5):488\u201396. https:\/\/doi.org\/10.1016\/j.cjco.2022.02.001.","journal-title":"CJC Open"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01728-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-023-01728-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-023-01728-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:07:53Z","timestamp":1725610073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-023-01728-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["1728"],"URL":"https:\/\/doi.org\/10.1007\/s10840-023-01728-0","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Patrick Badertscher has received research funding from the \u201cUniversity of Basel,\u201d the \u201cStiftung f\u00fcr Herzschrittmacher und Elektrophysiologie,\u201d the \u201cFreiwillige Akademische Gesellschaft Basel,\u201d the \u201cSwiss Heart Foundation,\u201d and Johnson&Johnson, and reports personal fees from BMS, Boston Scientific, and Abbott, all outside the submitted work.Philipp Krisai reports speaker fees from BMS.Sven Knecht has received funding from the \u201cStiftung f\u00fcr Herzschrittmacher und Elektrophysiologie.\u201dChristian Sticherling: Member of Medtronic Advisory Board Europe and Boston Scientific Advisory Board Europe, received educational grants from Biosense Webster and Biotronik and a research grant from the European Union\u2019s FP7 program and Biosense Webster and lecture and consulting fees from Abbott, Medtronic, Biosense Webster, Boston Scientific, Microport, and Biotronik all outside the submitted work.Michael K\u00fchne reports grants from the Swiss National Science Foundation (Grant numbers 33CS30_148474, 33CS30_177520, 32473B_176178, 32003B_197524), the Swiss Heart Foundation, the Foundation for Cardiovascular Research Basel, and the University of Basel; grants from Bayer; grants from Pfizer; grants from Boston Scientific; grants from BMS; grants from Biotronik; and grants and personal fees from Daiichi Sankyo, all outside the submitted work.Others have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}